Position history for BlackRock, Inc.'s holdings in IMMUNITYBIO INC
BlackRock, Inc. holds 26.3M shares of IBRX (IMMUNITYBIO INC), worth $202.1M as of 2026-Q1. The position was increased (+2.9% shares). IBRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$202.1M
Current Shares
26.3M
Total Value Change
+$167.3M
Total Shares Change
+12.8M
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 26.3M |
+2.9% |
| $202.1M |
| 0.0% |
| $10.00 |
31 |
| 2025-Q4 | Increased | 25.6M | +29.2% | $50.7M | 0.0% | $1.98 | 37 |
| 2025-Q3 | Increased | 19.8M | +11.5% | $48.7M | 0.0% | $2.57 | 33 |
| 2025-Q2 | Increased | 17.8M | +33.7% | $46.9M | 0.0% | $2.70 | 38 |
| 2025-Q1 | Decreased | 13.3M | -2.2% | $40M | 0.0% | $3.14 | 0 |
| 2024-Q4 | New | 13.6M | - | $34.8M | 0.0% | $2.68 | 40 |